DAVENPORT & Co LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 35 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
DAVENPORT & Co LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2022$23,000
-4.2%
22,0000.0%0.00%
Q2 2022$24,000
+84.6%
22,000
+83.3%
0.00%
Q1 2022$13,000
+30.0%
12,0000.0%0.00%
Q4 2021$10,000
-79.2%
12,000
-66.7%
0.00%
Q3 2021$48,000
+108.7%
36,000
+200.0%
0.00%
Q2 2021$23,000
-57.4%
12,0000.0%0.00%
-100.0%
Q1 2021$54,00012,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Burrage Capital Management LLC 2,125,585$9,480,0007.68%
DAFNA Capital Management LLC 1,204,825$5,374,0001.28%
Psagot Value Holdings Ltd. 3,095,741$13,807,0000.31%
Ground Swell Capital, LLC 14,684$65,0000.21%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 445,171$1,985,000,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,591$1,350,0000.02%
Phoenix Holdings Ltd. 244,113$1,089,0000.02%
Virtu Financial LLC 27,744$124,0000.01%
D.A. DAVIDSON & CO. 130,700$583,0000.01%
Schonfeld Strategic Advisors LLC 89,278$399,0000.01%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders